# SEVELAMER CARBONATE
> **ANDA203860** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2017-10-26
## Drug
- **FDA Application Number:** ANDA203860
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SEVELAMER CARBONATE
- **Generic name:** SEVELAMER CARBONATE
- **Active ingredients:** SEVELAMER CARBONATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Exelan Pharmaceuticals Inc.
- **First approval:** 2017-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203860)
---
*MORVS · CC0 1.0*